Medicsight Launches ColonCAD(TM) Online CTC Platform

NEW YORK, June 29 /PRNewswire-FirstCall/ -- Medicsight PLC, a subsidiary of
MGT Capital Investments, Inc. (NYSE AMEX: MGT) and an industry leader in the
development of Computer-Aided Detection (CAD) and image analysis software that
assists radiologists in the early detection of disease, is pleased to announce
the launch of its online product, MedicRead(TM) 3.0 Colon. This online
offering makes the benefits of Medicsight's ColonCAD software truly accessible
to all radiologists for the first time.

MedicRead(TM) 3.0 Colon is Medicsight's advanced visualization platform that
includes the Company's ColonCAD(TM) software. MedicRead(TM) 3.0 Colon allows
radiologists to read computer tomography (CT) scans for the detection of
colonic polyps, which may be the precursors of colon cancer. MedicRead(TM)
3.0 Colon can be downloaded from the Internet at www.medicsight.com and will
be sold as a total solution with either a single list price or available on a
monthly installment basis over 12 months.

Allan Rowley, Chief Executive of Medicsight, commented, "The launch of the
online MedicRead 3.0 Colon platform provides us with an additional
distribution channel for our exciting ColonCAD(TM) software. The MedicRead
3.0 Colon platform is currently the only visualization workstation for virtual
colonoscopy that can be accessed and downloaded via the Internet. This broad
access allows us to reach a broader user base and allows the international
radiology community the ability to take advantage of the clinical benefits of
our ColonCAD."

Access to Medicsight's ColonCAD(TM) software is currently available through
its partners' advanced 3D visualization platforms. As part of Medicsight's
ongoing commitment to radiologists and to improving the early detection of
colorectal cancer, Medicsight has developed MedicRead 3.0 Colon. This is a
competitively priced, standalone, CTC visualization workstation that
incorporates the latest version of ColonCAD 4.0 as well as Medicsight's
MedicServer(TM) technology. MedicRead 3.0 Colon offers a valuable centralized
pre-processing platform that accepts DICOM CT image data from either the CT
console or any PACS system.

A 30-day free trial version of the software can be downloaded from the
Medicsight new website www.medicsight.com, allowing radiologists to experience
the benefits of ColonCAD first-hand.

The new online application was showcased at the Medicsight booth at ESGAR
2009, which took place last week in Valencia, Spain.

Medicsight's ColonCAD technology has been approved for use in the European
Union, China, Canada and Brazil. MedicRead 3.0 Colon is not currently
available for sale in the United States.

About MGT Capital Investments, Inc.

MGT Capital Investments, Inc. is a technology holding company that focuses on
investments in the global healthcare information technology market. The
Company has two subsidiaries, Medicsight PLC and Medicexchange Ltd.

Medicsight PLC (AIM: MDST) is a UK-headquartered, research driven, leading
developer of computer-aided detection (CAD) and image analysis software for
the medical imaging market. The CAD software automatically highlights
suspicious areas on computerized tomography (CT) scans of the colon and lung,
helping radiologists to identify, measure and analyze potential disease and
early indicators of disease. Medicsight's CAD software has been validated
using one of the world's largest and most population diverse databases of
verified patient CT scan data. Medicsight's ColonCAD(TM) and LungCAD(TM)
software products are seamlessly integrated with the advanced 3D visualization
workstations of several industry-leading imaging equipment partners.

Medicexchange Ltd. provides medical imaging professionals with a global web
portal containing an online sales, jobs and information channel for
diagnostic, treatment and surgery planning solutions. This combined with a
variety of relevant clinical papers, training materials and content gives
these professionals access to information and products that they otherwise
would have difficulty accessing.

Additional information can be found at www.mgtci.com.

All forward-looking statements are made pursuant to the 'safe harbor'
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements are based on current management expectations that
involve risks and uncertainties that may result in such expectations not being
realized. Potential risks and uncertainties include, but are not limited to,
the risks described in company filings with the Securities and Exchange
Commission.

SOURCE MGT Capital Investments, Inc.

Todd Fromer, +1-212-896-1215, tfromer@kcsa.com, or Garth Russell,
+1-212-896-1250, grussell@kcsa.com, both of KCSA Strategic Communications